These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9696932

  • 21. The effect of butylated hydroxytoluene on the growth of enzyme-altered foci in male Fischer 344 rat liver tissue.
    Lok E, Mehta R, Jee P, Laver G, Nera EA, McMullen E, Clayson DB.
    Carcinogenesis; 1995 May; 16(5):1071-8. PubMed ID: 7767967
    [Abstract] [Full Text] [Related]

  • 22. 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced hepatocarcinogenesis is not enhanced by CYP1A inducers, alpha- and beta-naphthoflavone: relationship to intralobular distribution of CYP1A expression.
    Suzuki S, Takeshita K, Doi Y, Asamoto M, Takahashi S, Naiki-Ito A, Shirai T.
    Toxicol Pathol; 2010 Jun; 38(4):583-91. PubMed ID: 20448087
    [Abstract] [Full Text] [Related]

  • 23. Effects of chronic administration of low doses of 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline on glutathione S-transferase placental form-positive foci development in the livers of rats fed a choline-deficient diet.
    Sone H, Wakabayashi K, Kushida H, Ochiai M, Sugimura T, Nagao M.
    Jpn J Cancer Res; 1993 Aug; 84(8):859-64. PubMed ID: 8407550
    [Abstract] [Full Text] [Related]

  • 24. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin in induction of foci of rat liver cells containing the placental form of glutathione S-transferase.
    Thamavit W, Tatematsu M, Ogiso T, Mera Y, Tsuda H, Ito N.
    Cancer Lett; 1985 Jul; 27(3):295-303. PubMed ID: 2861889
    [Abstract] [Full Text] [Related]

  • 25. Modifying effects of concomitant treatment with butylated hydroxyanisole or butylated hydroxytoluene on N,N-dibutylnitrosamine-induced liver, forestomach and urinary bladder carcinogenesis in F344 male rats.
    Imaida K, Fukushima S, Inoue K, Masui T, Hirose M, Ito N.
    Cancer Lett; 1988 Dec 15; 43(3):167-72. PubMed ID: 3203335
    [Abstract] [Full Text] [Related]

  • 26. Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats.
    Tatematsu M, Mera Y, Ito N, Satoh K, Sato K.
    Carcinogenesis; 1985 Nov 15; 6(11):1621-6. PubMed ID: 2865013
    [Abstract] [Full Text] [Related]

  • 27. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis.
    Chattopadhyay MB, C B MK, Kanna PS, Ray RS, Roy S, Chatterjee M.
    J Gastroenterol Hepatol; 2004 Jun 15; 19(6):683-93. PubMed ID: 15151625
    [Abstract] [Full Text] [Related]

  • 28. Suppression of glutathione S-transferase placental form-positive foci development in rat hepatocarcinogenesis by Chlorella pyrenoidosa.
    Takekoshi H, Mizoguchi T, Komasa Y, Chubachi H, Inoue Y, Imanishi H, Nakano M.
    Oncol Rep; 2005 Aug 15; 14(2):409-14. PubMed ID: 16012723
    [Abstract] [Full Text] [Related]

  • 29. Inhibitory effects of ethoxyquin, 4,4'-diaminodiphenylmethane and acetaminophen on rat hepatocarcinogenesis.
    Masui T, Tsuda H, Inoue K, Ogiso T, Ito N.
    Jpn J Cancer Res; 1986 Mar 15; 77(3):231-7. PubMed ID: 3084413
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Induction of DNA-adducts and increase of 8-hydroxy-2-deoxyguanosine, but no development of preneoplastic lesions in offspring liver with transplacental and trans-breast milk exposure to 2-amino-3,8-dimethylimidazo [4,5-f ]quinoxaline (MeIQx) in rats.
    Ichihara T, Wanibuchi H, Totsuka Y, Morimura K, Wei M, Nakae D, Fukushima S.
    Cancer Sci; 2004 Dec 15; 95(12):943-8. PubMed ID: 15596042
    [Abstract] [Full Text] [Related]

  • 36. Post-initiation inhibition of MeIQx hepatocarcinogenesis in rats by cysteine.
    Ogawa M, Wanibuchi H, Nishkawa T, Yano Y, Otani S, Totsuka Y, Wakabayashi K, Nakae D, Fukushima S.
    Osaka City Med J; 2003 Jun 15; 49(1):21-30. PubMed ID: 14703096
    [Abstract] [Full Text] [Related]

  • 37. Modulation of azaserine-induced pancreatic foci by phenolic antioxidants in rats.
    Roebuck BD, MacMillan DL, Bush DM, Kensler TW.
    J Natl Cancer Inst; 1984 Jun 15; 72(6):1405-10. PubMed ID: 6610071
    [Abstract] [Full Text] [Related]

  • 38. Dose-dependent induction of 8-hydroxyguanine and preneoplastic foci in rat liver by a food-derived carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, at low dose levels.
    Kato T, Hasegawa R, Nakae D, Hirose M, Yaono M, Cui L, Kobayashi Y, Konishi Y, Ito N, Shirai T.
    Jpn J Cancer Res; 1996 Feb 15; 87(2):127-33. PubMed ID: 8609060
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Synthetic phenolic antioxidants: Metabolism, hazards and mechanism of action.
    Xu X, Liu A, Hu S, Ares I, Martínez-Larrañaga MR, Wang X, Martínez M, Anadón A, Martínez MA.
    Food Chem; 2021 Aug 15; 353():129488. PubMed ID: 33714793
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.